tiprankstipranks
Trending News
More News >
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market
Advertisement

Bio-Gene Technology Ltd. (BGT) Price & Analysis

Compare
6 Followers

BGT Stock Chart & Stats


Financials

BGT FAQ

What was Bio-Gene Technology Ltd.’s price range in the past 12 months?
Bio-Gene Technology Ltd. lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.
    What is Bio-Gene Technology Ltd.’s market cap?
    Bio-Gene Technology Ltd.’s market cap is AU$6.41M.
      When is Bio-Gene Technology Ltd.’s upcoming earnings report date?
      Bio-Gene Technology Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 23 days.
        How were Bio-Gene Technology Ltd.’s earnings last quarter?
        Currently, no data Available
        Is Bio-Gene Technology Ltd. overvalued?
        According to Wall Street analysts Bio-Gene Technology Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bio-Gene Technology Ltd. pay dividends?
          Bio-Gene Technology Ltd. does not currently pay dividends.
          What is Bio-Gene Technology Ltd.’s EPS estimate?
          Bio-Gene Technology Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Bio-Gene Technology Ltd. have?
          Bio-Gene Technology Ltd. has 305,061,100 shares outstanding.
            What happened to Bio-Gene Technology Ltd.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Bio-Gene Technology Ltd.?
            Currently, no hedge funds are holding shares in AU:BGT

            Company Description

            Bio-Gene Technology Ltd.

            Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
            Similar Stocks
            Company
            Price & Change
            Follow
            Zelira Therapeutics
            Invex Therapeutics Ltd.
            Regeneus Ltd.
            AdAlta Ltd.
            Hexima Ltd
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis